Oncogene deal

ONCS (Uniondale, N.Y.) and American Home Products' Wyeth-Ayerst division extended their 1992 collaboration to develop orally delivered, gene transcription-based drugs to treat diabetes, asthma and osteoporosis, and to develop immune system modulators. The compounds now will be moved into preclinical development. ...